Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 21/07/19971 min de leitura
Oral Dosage Form New Animal Drugs; Enrofloxacin Tablets
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Bayer Corp., Agriculture Division, Animal Health. The supplemental NADA provides for revised conditions for use (dose, indications, and limitations) of enrofloxacin tablets in dogs and cats for the management of diseases associated with bacteria susceptible to enrofloxacin.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →